Spring 2012

Cancer Genetics and Genomics Forum

2240 CIEMAS

 

Mondays 1:00pm

(Unless otherwise noted)

 

Date

Presenter

Topic

Slides

Jan. 23

Dr. Sandeep Dave

Microarrays, Deep Sequencing and Beyond: The Promise and Peril of High Throughput Technologies in Cancer

 

Jan. 30

 

No Meeting

 

 

Feb. 6

Dr. Chuan-Yuan Li

Phoenix Rising and Wheel of Life: Redefining the Roles Caspases in Tumor Therapy, Tissue Regeneration, and Stem Cells

 

Feb. 13

Dr. Raluca Gordan

Applications of Protein Binding Microarrays to Cancer Genomics

 

Feb. 20

Dr. Ashley Chi

Microenvironmental Stresses and Nutrient Requirement of Tumors

 

Feb. 27

Dr. Herbert Hurwitz

Biomarkers for Anti-VEGF Therapy:  An Update

 

Mar. 5

Dr. Matthew Hirschey

Protein Acetylation Induces Hepatocellular Carcinoma

 

 

Mar. 12

Dr. Sam Mbulaiteye

(Natl. Cancer Inst.)

Endemic ,Sporadic and AIDS-related Burkitt Lymphoma: Epidemiological Patterns May Be Clue to Molecular Heterogeneity

 

 

Mar. 19

Dr. Micah Luftig

Studies at the Oncogenic Virus/Host Interface: Dynamic Regulation of Epstein-Barr Virus-Mediated B Cell Immortalization

 

Mar. 26

Dr. Terry Furey, UNC Chapel Hill

Integrating Genomic Data in Complex Disease Analysis

 

April 2

Dr. Sayan Mukherjee

Integrating Genetic and Gene Expression Evidence into Genome-wide Association Analysis of Gene Sets and a Bayesian Mixed Effects Model of Differential Expression for RNAseq Data

 

April 9

NO CG&G Forum

 

 

April 16

Dr. David Kirsch

Using a Genetically Engineered Mouse Model of Sarcoma to Identify miRNAs that Regulate Metastasis

 

April 23

Dr. W. Kimryn Rathmell,

UNC Chapel Hill

Lineberger Comprehensive Cancer Center

 

Tumor Heterogeneity in Renal Cell Carcinoma

 

April 30

Dr. William Kim,

UNC Chapel Hill Lineberger Comprehensive Cancer Center

Erythropoietin and Solid Tumorigenesis

 

 

May 7

Dr. Charles Perou,

UNC Chapel Hill

Lineberger Comprehensive Cancer Center

Therapeutic Implications of the Molecular Portraits of Breast Cancer

 

May 14

Dr. Donald Fox

Roles for Polyploidy in De-stabilizing the Genome

 

May 21

Dr. Michael Kastan

Executive Director,

Duke Cancer Institute

DNA Damage Responses: Bedside to Bench to Bedside”

 

June 4

Dr. Joseph Lucas

Techniques for Utilizing Public Datasets